KWM
RMD icon

Kingsview Wealth Management’s ResMed RMD Stock Holding History

Kingsview Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,316
Closed -$347K – 1027
2021
Q3 		$347K Hold
1,316
– – 0.02% 648
2021
Q2 		$326K Buy
+1,316
New +$277K 0.02% 675

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Kingsview Wealth Management's RMD Position: Q4 2021 in Review

Kingsview Wealth Management sold out of ResMed (RMD) in Q4 2021, closing a stake of 1,316 shares — an estimated $347K sold.

Kingsview Wealth Management first reported a position in RMD in Q2 2021 and held it in 2 quarters. The position peaked at $347K in Q3 2021. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • Kingsview Wealth Management reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
  • Kingsview Wealth Management sold 1,316 ResMed shares in Q4 2021, an estimated $347K.
  • Kingsview Wealth Management first reported a position in ResMed in Q2 2021 and held it in 2 quarters.
  • Kingsview Wealth Management's ResMed position peaked at $347K in Q3 2021.
  • 723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Kingsview Wealth Management's 13F filing for Q4 2021, filed 17 Feb 2022.